World Heart Day is proud to partner with Amgen and Servier.
Our global partners support World Heart Day in our mission to reduce cardiovascular disease (CVD) globally and drive urgent action. Collaboration on a global scale means we can help people live longer, better and healthier lives all over the world.
Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. A biotechnology company, Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients. Amgen helped establish the biotechnology industry more than 40 years ago and remains on the cutting-edge of innovation, using technology and human genetic data to push beyond what’s known today.
Servier is a global pharmaceutical group governed by a Foundation. With a strong international presence in 150 countries and a total revenue of 4.7 billion euros in 2020, Servier employs 22,500 people worldwide. Servier is an independent group that invests over 20% of its brand-name revenue in Research and Development every year.
Becoming a partner of World Heart Day means you can help increase its impact and spread awareness of CVD far and wide.
Become a partner
